Lvis Junior
Device Neurological Product
PDI 00811425029893
General payments
$65,172
Research payments
$143,427
Through program year 2025, $65,172 in general payments and $143,427 in research payments were reported against Lvis Junior (Neurological Product).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $795 | 10 |
| 2024 | General | $49,756 | 346 |
| 2024 | Research | $37,609 | 7 |
| 2023 | General | $7,813 | 99 |
| 2023 | Research | $105,818 | 12 |
| 2022 | General | $6,808 | 49 |
Breakdown
The top 5 of 10 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
504 general · 19 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.